• Home
  • About OptiScan
    • About OptiScan
    • Leadership
    • Board of Directors
  • Clinical Results
    • Clinical Results
    • Clinical Benefits
  • Technology/Products
    • Technology/Products
    • OptiScanner 5000
    • FAQs
  • Careers
  • News and Events
  • Contact Us
  • Home
  • About OptiScan
    • About OptiScan
    • Leadership
    • Board of Directors
  • Clinical Results
    • Clinical Results
    • Clinical Benefits
  • Technology/Products
    • Technology/Products
    • OptiScanner 5000
    • FAQs
  • Careers
  • News and Events
  • Contact Us

Archives

Author Archive for: "Optiscan"
Home /
By Optiscan
In Press Releases
Posted March 20, 2019

OptiScan Biomedical Completes $20 Million Series E Financing

Proceeds to Support U.S. Commercialization of OptiScanner 5000 and Ongoing Platform Expansion Company’s First-of-its-Kind Continuous Monitoring Platform for Intensive Care Units to be Highlighted [...]

Read More
By Optiscan
In Press Releases
Posted May 22, 2018

OptiScan Biomedical Announces Appointment of Cary G. Vance as President and Chief Executive Officer

Hayward, CA, May 22, 2018 – OptiScan Biomedical Corporation, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit (SICU), today announced [...]

Read More
RECENT RELEASES
  • OptiScan Biomedical Receives CE Mark for OptiScanner ® 7000 for Automated Multivariate Monitoring of Metabolic and Hemodynamic Status of Patients in the Intensive Care Unit
    May 12, 2020
  • OptiScan Biomedical Announces Peer-Reviewed Publications Highlighting First-of-its-Kind Continuous Monitoring Platform for Intensive Care Units
    December 7, 2019
  • OptiScan Biomedical Completes $20 Million Series E Financing
    March 20, 2019





Copyright ©2018 OptiScan. All Rights Reserved.